Fresenius Medical Care AG & Co. (FMS) reported first-quarter 2025 adjusted earnings per share (EPS) of 44 cents, which surpassed the Zacks Consensus Estimate by 2.1%. The bottom line improved 22.2% year over year. (Find the latest EPS estimates and surprises on Zacks Earnings Calendar.)FMS’ Revenue DetailsRevenues of $5.14 billion (EUR 4,881 million) missed the Zacks Consensus Estimate by 2.2%. The company’s reported revenues increased 3.3% year over year and 1.2% at constant currency (cc). Also, revenues w ...